APOE and Alzheimer disease: Specifically, individuals carrying one copy of the APOE4 allele have a higher risk of developing AD compared to non-carriers, and those with two copies exhibit an even greater risk, highlighting the dose-dependent contribution of APOE4 to AD susceptibility.